False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma

被引:22
作者
Ford, Clyde D.
Gabor, Frank
Morgan, Ross
Dabbas, Bashar
机构
[1] Latter Day St Hosp, Utah Blood & Marrow Transplant Program, Dept Med, Salt Lake City, UT 84143 USA
[2] Latter Day St Hosp, Dept Radiol, Salt Lake City, UT 84143 USA
[3] Latter Day St Hosp, Dept Pathol, Salt Lake City, UT 84143 USA
关键词
PET scanning; spleen;
D O I
10.1097/01.rlu.0000222952.30225.66
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We report 2 patients with aggressive non-Hodgkin lymphoma who had positive restaging PET scans limited to the spleen and no significant uptake in nodal areas of previously known disease. Examination of the resected spleens from both patients revealed extensive inflammation surrounding necrotic tumor with no evidence of viable lymphoma or active infection. It is suggested that close observation of such patients for evidence of progressive disease may be considered as opposed to immediate intervention.
引用
收藏
页码:391 / 393
页数:3
相关论文
共 11 条
[1]   Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma [J].
Cremerius, U ;
Fabry, U ;
Neuerburg, J ;
Zimny, M ;
Osieka, R ;
Buell, U .
NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (11) :1055-1063
[2]   Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma [J].
deWit, M ;
Bumann, D ;
Beyer, W ;
Herbst, K ;
Clausen, M ;
Hossfeld, DK .
ANNALS OF ONCOLOGY, 1997, 8 :57-60
[3]   Positron emission tomography scanning in the assessment of patients with lymphoma [J].
Foo, SS ;
Mitchell, PL ;
Berlangieri, SU ;
Smith, CL ;
Scott, AM .
INTERNAL MEDICINE JOURNAL, 2004, 34 (07) :388-397
[4]  
GURTON C, 2004, BRIT J HAEMATOL, V126, P772
[5]   Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen [J].
Magrath, I ;
Adde, M ;
Shad, A ;
Venzon, D ;
Seibel, N ;
Gootenberg, J ;
Neely, J ;
Arndt, C ;
Nieder, M ;
Jaffe, E ;
Wittes, RA ;
Horak, ID .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :925-934
[6]  
Metser U, 2005, J NUCL MED, V46, P52
[7]   18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT [J].
Mikhaeel, NG ;
Timothy, AR ;
O'Doherty, MJ ;
Hain, S ;
Maisey, MN .
LEUKEMIA & LYMPHOMA, 2000, 39 (5-6) :543-553
[8]   Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma [J].
Mikosch, P ;
Gallowitsch, HJ ;
Zinke-Cerwenka, W ;
Heinisch, M ;
Pipam, W ;
Eibl, M ;
Kresnik, E ;
Unterweger, O ;
Linkesch, W ;
Lind, P .
ACTA MEDICA AUSTRIACA, 2003, 30 (02) :41-47
[9]   Extranodal malignant lymphoma: Detection with FDG PET versus CT [J].
Moog, F ;
Bangerter, M ;
Diederichs, CC ;
Guhlmann, A ;
Merkle, E ;
Frickhofen, N ;
Reske, SN .
RADIOLOGY, 1998, 206 (02) :475-481
[10]  
Rini JN, 2003, J NUCL MED, V44, P1072